For patients with heart failure or chronic kidney disease, SGLT2 inhibitors are generally preferred first, with GLP-1 agonists considered when SGLT2 inhibitors are contraindicated or not tolerated
10.1161/CIRCRESAHA.118.312673 67 PfefferM
Use of Ozempic and Mounjaro, known as 'GLP-1 drugs,' has surged in recent years, with prescriptions increasing by more than 400% from 2019 to 2023, according to a report by the health policy organization KFF
The blend offers several advantages over synthetic growth hormone: More natural pulsatile release Lower cost Fewer side effects Legal status (for research purposes) Maintains natural feedback mechanisms However, synthetic GH produces more dramatic results at higher doses
doi:10.1186/1741-7015-11-205, PMID: 24229326 Morris G, Maes M (2014) Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways